外科理论与实践 ›› 2022, Vol. 27 ›› Issue (02): 93-94.doi: 10.16139/j.1007-9610.2022.02.001
• 述评 • 下一篇
汤钊猷(
)
收稿日期:2021-12-01
出版日期:2022-05-25
发布日期:2022-06-16
通讯作者:
汤钊猷
E-mail:zytang88@163.com
TANG Zhaoyou()
Received:2021-12-01
Online:2022-05-25
Published:2022-06-16
Contact:
TANG Zhaoyou
E-mail:zytang88@163.com
中图分类号:
汤钊猷. 中华哲学思维对肝癌治疗的启迪[J]. 外科理论与实践, 2022, 27(02): 93-94.
TANG Zhaoyou. Enlightenment of Chinese philosophic thinking on treatment of liver cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 93-94.
| [1] |
Kelley RK. Atezolizumab plus bevacizumab—a landmark in liver cancer[J]. N Engl J Med, 2020, 382(20):1953-1955.
doi: 10.1056/NEJMe2004851 URL |
| [2] |
Zahalka AH, Frenette PS. Nerves in cancer[J]. Nat Rev Cancer, 2020, 20(3):143-157.
doi: 10.1038/s41568-019-0237-2 pmid: 31974491 |
| [3] |
Gao X, Sanderson SM, Dai Z, et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism[J]. Nature, 2019, 572(7769):397-401.
doi: 10.1038/s41586-019-1437-3 URL |
| [4] |
Kanarek N, Petrova B, Sabatini DM. Dietary modifications for enhanced cancer therapy[J]. Nature, 2020, 579(7800):507-517.
doi: 10.1038/s41586-020-2124-0 URL |
| [5] |
Saeb-Parsy K, Wynn TA, Vallier L, et al. Plant-based and animal-based low-carbohydrate diets and risk of he-patocellular carcinoma among US men and women[J]. Hepatology, 2021, 73(1):175-185.
doi: 10.1002/hep.31251 URL |
| [6] |
Zhang KZ, Zhang QB, Zhang QB, et al. Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model[J]. J Hematol Oncol, 2014, 7:28.
doi: 10.1186/1756-8722-7-28 URL |
| [7] |
Loh SN. Arsenic and an old place: rescuing p53 mutants in cancer[J]. Cancer Cell, 2021, 39(2):140-142.
doi: 10.1016/j.ccell.2021.01.012 URL |
| [8] | Liao SF, Koshiol J, Huang YH, et al. Postdiagnosis aspirin use associated with decreased biliary tract cancer-specific mortality in a large nationwide cohort[J]. He-patology, 2021, 74(4):1994-2006. |
| [9] |
Choi J, Jo C, Lim YS. Tenofovir versus entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection[J]. Hepatology, 2021, 73(2):661-673.
doi: 10.1002/hep.31289 URL |
| [10] |
Goh MJ, Sinn DH, Kim S, et al. Statin use and the risk of hepatocellular carcinoma in patients with chronic he-patitis B[J]. Hepatology, 2020, 71(6):2023-2032.
doi: 10.1002/hep.30973 URL |
| [11] |
Prasad V. Our best weapons against cancer are not magic bullets[J]. Nature, 2020, 577(7791):451.
doi: 10.1038/d41586-020-00116-2 URL |
| [12] |
Zheng H, Pomyen Y, Hernandez MO, et al. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma[J]. Hepatology, 2018, 68(1):127-140.
doi: 10.1002/hep.29778 URL |
| [1] | 叶枫, 龚笑勇, 任家俊, 蔡强, 陈胜. ERCP在原发性肝癌围术期胆道并发症诊治中的应用[J]. 外科理论与实践, 2023, 28(04): 355-360. |
| [2] | Chang Jessica, 陈旭晓, 陈拥军. 脾脏在肝癌合并肝硬化中的临床价值[J]. 外科理论与实践, 2023, 28(04): 394-398. |
| [3] | 张辉, 龚玲, 郭茜, 罗艳. 肝癌全身麻醉射频消融术后应用舒更葡糖钠逆转神经肌肉阻滞的回顾性研究[J]. 外科理论与实践, 2023, 28(01): 72-76. |
| [4] | 陈聪燕 综述, 王俊青, 陈拥军 审校. 肠道菌群与肝癌的发病机制[J]. 外科理论与实践, 2022, 27(03): 256-260. |
| [5] | 朱鹏, 廖威, 张必翔, 陈孝平. 机器人肝癌肝切除应用现状与前景[J]. 外科理论与实践, 2022, 27(02): 95-99. |
| [6] | 曹君, 陈亚进. 腹腔镜解剖性肝切除治疗肝癌的规范与思考[J]. 外科理论与实践, 2022, 27(02): 123-127. |
| [7] | 任家俊, 陈拥军. 肝脾联合切除治疗原发性肝癌合并门静脉高压及脾功能亢进[J]. 外科理论与实践, 2022, 27(02): 139-144. |
| [8] | 苏长青. 从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433. |
| [9] | 吴冬梅, 吴丽莉, 陈佳, 刘坤. 淋巴上皮样肝细胞肝癌一例报告附文献复习[J]. 诊断学理论与实践, 2021, 20(05): 498-501. |
| [10] | 汪楠, 郝风节, 王俊青. 肝细胞多倍体发生机制及其与肝细胞癌形成的相关性研究进展[J]. 诊断学理论与实践, 2020, 19(06): 618-621. |
| [11] | 陈鹏, 李涛. 胞外囊泡携带的非编码RNA在肝癌发生、发展中的作用[J]. 外科理论与实践, 2020, 25(05): 447-451. |
| [12] | 张倜, 杨雪娇. 肝癌靶向治疗相关高血压的发生与处置[J]. 外科理论与实践, 2020, 25(01): 29-34. |
| [13] | 叶枫, 马迪, 陈拥军. 肝癌破裂出血规范化治疗探讨[J]. 外科理论与实践, 2020, 25(01): 1-5. |
| [14] | 黄成, 孙惠川. 《原发性肝癌诊疗规范（2019年版）》肝脏外科领域更新的展望[J]. 外科理论与实践, 2020, 25(01): 6-9. |
| [15] | 石明, 何敏柯, 陈敏山. 肝动脉灌注化疗的现状与前景[J]. 外科理论与实践, 2020, 25(01): 10-14. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
